HK1216440A1 - 用於補體因子 相關蛋白質 檢測的試劑、試劑盒和方法 - Google Patents
用於補體因子 相關蛋白質 檢測的試劑、試劑盒和方法Info
- Publication number
- HK1216440A1 HK1216440A1 HK16104365.1A HK16104365A HK1216440A1 HK 1216440 A1 HK1216440 A1 HK 1216440A1 HK 16104365 A HK16104365 A HK 16104365A HK 1216440 A1 HK1216440 A1 HK 1216440A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- kits
- agents
- detection
- methods
- related protein
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13156823 | 2013-02-26 | ||
PCT/EP2014/053493 WO2014131714A1 (en) | 2013-02-26 | 2014-02-24 | Agents, kits and methods for complement factor h-related protein 1 detection |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1216440A1 true HK1216440A1 (zh) | 2016-11-11 |
Family
ID=47832928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16104365.1A HK1216440A1 (zh) | 2013-02-26 | 2016-04-18 | 用於補體因子 相關蛋白質 檢測的試劑、試劑盒和方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20150355199A1 (zh) |
EP (1) | EP2962106A1 (zh) |
JP (1) | JP2016510870A (zh) |
CN (1) | CN104995516A (zh) |
CA (1) | CA2901644A1 (zh) |
HK (1) | HK1216440A1 (zh) |
WO (1) | WO2014131714A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105628930A (zh) * | 2015-12-22 | 2016-06-01 | 山东博科生物产业有限公司 | 一种灵敏度高的胶乳增强免疫比浊法肌钙蛋白i检测试剂 |
CN106519030B (zh) * | 2016-12-22 | 2020-01-07 | 广州泰诺迪生物科技有限公司 | 补体因子h抑制剂及与之相关的用途 |
CN111650371A (zh) * | 2019-03-04 | 2020-09-11 | 深圳市第二人民医院 | 基于纳米酶的膀胱癌bta检测试纸条 |
CN113943369B (zh) * | 2021-10-27 | 2023-04-18 | 福州迈新生物技术开发有限公司 | 抗mum1蛋白单克隆抗体、细胞系及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6316607B1 (en) | 1986-04-30 | 2001-11-13 | Igen International, Inc. | Electrochemiluminescent assays |
US5935779A (en) | 1988-11-03 | 1999-08-10 | Igen International Inc. | Methods for improved particle electrochemiluminescence assay |
US5466416A (en) | 1993-05-14 | 1995-11-14 | Ghaed; Ali | Apparatus and methods for carrying out electrochemiluminescence test measurements |
US7604948B2 (en) * | 2005-05-05 | 2009-10-20 | The Regents Of The University Of California | Biomarkers for diagnosing an autism spectrum disorder |
WO2008008986A2 (en) * | 2006-07-13 | 2008-01-17 | University Of Iowa Research Foundation | Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration |
DE102008049136B4 (de) * | 2008-09-26 | 2012-10-25 | Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. | Neue Regulatoren des angeborenen Immunsystems |
JP2014527175A (ja) * | 2011-08-26 | 2014-10-09 | エフ.ホフマン−ラ ロシュ アーゲー | 精神発達、神経または神経精神障害の処置における臨床的有用性を予測するための方法 |
-
2014
- 2014-02-24 CN CN201480010215.XA patent/CN104995516A/zh active Pending
- 2014-02-24 JP JP2015558477A patent/JP2016510870A/ja active Pending
- 2014-02-24 EP EP14706552.8A patent/EP2962106A1/en not_active Ceased
- 2014-02-24 CA CA2901644A patent/CA2901644A1/en not_active Abandoned
- 2014-02-24 WO PCT/EP2014/053493 patent/WO2014131714A1/en active Application Filing
-
2015
- 2015-08-26 US US14/835,821 patent/US20150355199A1/en not_active Abandoned
-
2016
- 2016-04-18 HK HK16104365.1A patent/HK1216440A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20150355199A1 (en) | 2015-12-10 |
JP2016510870A (ja) | 2016-04-11 |
CA2901644A1 (en) | 2014-09-04 |
WO2014131714A1 (en) | 2014-09-04 |
EP2962106A1 (en) | 2016-01-06 |
CN104995516A (zh) | 2015-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212444A1 (zh) | 化驗裝置、方法和試劑 | |
EP3013512A4 (en) | Resistance welding fastener, apparatus and methods | |
EP2991679A4 (en) | POLYSPECIFIC REAGENTS, PROCESS FOR THEIR PREPARATION AND USE | |
EP2967590A4 (en) | INSULATION ARRANGEMENTS, PROCESSES AND KITS | |
GB2526758B (en) | Methods for artificially aging aluminum-zinc-magnesium alloys, and products based on the same | |
HK1218129A1 (zh) | 用於檢測 -二羥基維生素 的方法和試劑盒以及相關抗體 | |
EP3027120A4 (en) | Joining devices, kits and methods | |
PT3272874T (pt) | Composição de reagente para biossensor e biossensor tendo a mesma | |
EP3087202A4 (en) | Nucleic acid detection method and kit | |
HK1209799A1 (zh) | 種無創癌症檢測方法及其試劑盒 | |
EP2975394A4 (en) | Eddy current flaw detection device, eddy current flaw detection method, and eddy current flaw detection program | |
ZA201707114B (en) | Methods for detecting agglutination and compositions for use in practicing the same | |
EP3063302A4 (en) | Methods for determining chemosensitivity and chemotoxicity | |
EP3009501A4 (en) | Cell evaluation device, method, and program | |
EP2951580A4 (en) | ARTICLES AND METHODS FOR RAPID DETECTION OF THC | |
HK1222683A1 (zh) | 用於檢測藥物性耳聾易感性的試劑盒及方法 | |
EP2962105A4 (en) | METHODS AND REAGENTS FOR DETERMINING ISOMERIC ANALYTES | |
HK1250778A1 (zh) | 分析物檢測及其方法 | |
IL252118A0 (en) | Analytical methods and arrays for their use | |
HK1216440A1 (zh) | 用於補體因子 相關蛋白質 檢測的試劑、試劑盒和方法 | |
EP3265561A4 (en) | Kits and methods for pathogen detection | |
SG11201509866TA (en) | Protease-responsive peptide biosensors and methods for analyte detection | |
EP2985347A4 (en) | METHOD FOR DETECTING A PROTEIN STABILITY AND USES THEREOF | |
GB201303168D0 (en) | Immunoassay for detecting kratom, Its constituents and their use | |
GB201305940D0 (en) | Methods and arrays for use in the same |